Reports

Global Animal Stem Cell Therapy Market Data Survey Report 2015-2025

Summary Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively. The global Animal Stem Cell Therapy market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, sales data and product specifications etc.: MediVet Biologic VETSTEM BIOPHARMA J-ARM Celavet Magellan Stem Cells U.S. Stem Cell Cells Power Japan ANIMAL CELL THERAPIES Animal Care Stem Cell Therapy Sciences VetCell Therapeutics Animacel Aratana Therapeutics Major applications as follows: Veterinary Hospitals Research Organizations Major Type as follows: Dogs Horses Others Regional market size, production data and export & import: Asia-Pacific North America Europe South America Middle East & Africa

Last updated 12-30-2019 Read More

Global Aprotinin Market Data Survey Report 2015-2025

Summary Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss. The global Aprotinin market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, sales data and product specifications etc.: Sigma-Aldrich BeiJing Geyuantianrun Bio-tech Cayman Chemical Taj Pharmaceuticals Limited Guangdong Techpool Bio-pharma Dadeli A.S.Joshi&Company Enzymeking Biotechnology AdooQ BioScience ProSpec Yaxin Biotechnology AMRESCO PanReac AppliChem Runhao Major applications as follows: Pharmaceuticals Scientific Research & Experiment Major Type as follows: Aprotinin (From bovine lung) Recombinant Aprotinin Regional market size, production data and export & import: Asia-Pacific North America Europe South America Middle East & Africa

Last updated 12-30-2019 Read More